posted on 2021-12-03, 13:38authored bySlav A. Semerdzhiev, Mohammad A. A. Fakhree, Ine Segers-Nolten, Christian Blum, Mireille M. A. E. Claessens
First cases that
point at a correlation between SARS-CoV-2 infections
and the development of Parkinson’s disease (PD) have been reported.
Currently, it is unclear if there is also a direct causal link between
these diseases. To obtain first insights into a possible molecular
relation between viral infections and the aggregation of α-synuclein
protein into amyloid fibrils characteristic for PD, we investigated
the effect of the presence of SARS-CoV-2 proteins on α-synuclein
aggregation. We show, in test tube experiments, that SARS-CoV-2 spike
protein (S-protein) has no effect on α-synuclein aggregation,
while SARS-CoV-2 nucleocapsid protein (N-protein) considerably speeds
up the aggregation process. We observe the formation of multiprotein
complexes and eventually amyloid fibrils. Microinjection of N-protein
in SH-SY5Y cells disturbed the α-synuclein proteostasis and
increased cell death. Our results point toward direct interactions
between the N-protein of SARS-CoV-2 and α-synuclein as molecular
basis for the observed correlation between SARS-CoV-2 infections and
Parkinsonism.